Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Norway Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20054
20063
20071
20091
20121
20132
20142
20191
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Active, not recruiting1
No longer available1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb6
Novartis Pharmaceuticals6
Pfizer3
Amsterdam UMC, location VUmc1
European LeukemiaNet1
Mendus1
Norwegian University of Science and Technology1
St. Olavs Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive20
Leukemia4
Philadelphia Chromosome4
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Bone Marrow Diseases2
Bronchiolitis Obliterans Syndrome2
Leukemia, Myeloid2
Blast Crisis1
Hematologic Diseases1
Hematologic Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.